SUVRETTA CAPITAL MANAGEMENT, LLC - Q4 2021 holdings

$5.16 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 95 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .

 Value Shares↓ Weighting
MSFT NewMICROSOFT CORP$290,917,000865,000
+100.0%
5.63%
MNST NewMONSTER BEVERAGE CORP NEW$109,841,0001,143,700
+100.0%
2.13%
HLT NewHILTON WORLDWIDE HLDGS INC$93,441,000599,022
+100.0%
1.81%
MAR NewMARRIOTT INTL INC NEWcl a$81,569,000493,640
+100.0%
1.58%
DECK NewDECKERS OUTDOOR CORP$79,207,000216,230
+100.0%
1.53%
DHR NewDANAHER CORPORATION$72,448,000220,200
+100.0%
1.40%
NewRIVIAN AUTOMOTIVE INC$52,657,000507,830
+100.0%
1.02%
RARE NewULTRAGENYX PHARMACEUTICAL IN$40,804,000485,242
+100.0%
0.79%
ETSY NewETSY INC$26,745,000122,158
+100.0%
0.52%
MQ NewMARQETA INC$25,195,0001,467,368
+100.0%
0.49%
NewGRAB HOLDINGS LIMITEDclass a ord$14,260,0002,000,000
+100.0%
0.28%
PHVS NewPHARVARIS N V$11,908,000827,540
+100.0%
0.23%
AMAM NewAMBRX BIOPHARMA INCsponsored ads$9,551,0001,057,735
+100.0%
0.18%
NewROIVANT SCIENCES LTD$6,870,000681,528
+100.0%
0.13%
ABCL NewABCELLERA BIOLOGICS INCcall$5,250,000367,100
+100.0%
0.10%
ALLO NewALLOGENE THERAPEUTICS INC$3,956,000265,116
+100.0%
0.08%
NewOPY ACQUISITION CORP Iunit 09/22/2026$2,000,000200,000
+100.0%
0.04%
NewENTRADA THERAPEUTICS INC$1,815,000106,000
+100.0%
0.04%
MGTX NewMEIRAGTX HLDGS PLC$821,00034,600
+100.0%
0.02%
SRNE NewSORRENTO THERAPEUTICS INC$492,000105,744
+100.0%
0.01%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ADOBE SYSTEMS INCORPORATED33Q4 202113.2%
CONSTELLATION BRANDS INC20Q4 201810.9%
AMAZON COM INC20Q3 20238.0%
UNITEDHEALTH GROUP INC20Q3 20235.7%
IQVIA HLDGS INC19Q3 20237.3%
RESTAURANT BRANDS INTL INC18Q3 20198.9%
UNION PAC CORP17Q2 20235.1%
META PLATFORMS INC16Q3 202310.9%
COPART INC15Q4 20212.3%
SUTRO BIOPHARMA INC15Q3 20231.9%

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SUVRETTA CAPITAL MANAGEMENT, LLC Q4 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Zura Bio LtdJune 15, 20232,850,0006.6%
InflaRx N.V.April 24, 20235,733,91010.3%
Benitec Biopharma Inc.April 18, 20233,020,21410.0%
Aeglea BioTherapeutics, Inc.February 13, 20236,376,37310.0%
Bolt Biotherapeutics, Inc.Sold outFebruary 13, 202300.0%
Cano Health, Inc.Sold outFebruary 13, 202300.0%
CHIMERIX INCSold outFebruary 13, 202300.0%
Disc Medicine, Inc.Sold outFebruary 13, 202300.0%
OTONOMY, INC.Sold outFebruary 13, 202300.0%
Sio Gene Therapies Inc.Sold outFebruary 13, 202300.0%

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
32024-05-02
SC 13D2024-04-29
SC 13G2024-04-15
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.

Compare quarters

Export SUVRETTA CAPITAL MANAGEMENT, LLC's holdings